Zymeworks Announces Appointment of Derek J. Miller to its Board of Directors
VANCOUVER, BC — (BUSINESS WIRE) — Zymeworks Inc. (Nasdaq: ZYME), a clinical-stage biotechnology company developing novel, multifunctional biotherapeutics, today announced the appointment of Derek J. Miller to its board of… Read More




